drugset / Trial / NCT02450175

Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls

NCT02450175

Unknown 50 enrolled Sinai Hospital of Baltimore
RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this research study is to understand if platelets in the blood become more active during cancer and specially advanced stages of cancer, in the future the investigators want to see if reducing platelet activity can improve survival in advanced cancer.

Timeline

Start
2014-06
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Everolimus Small molecule 10 mg Oral
Comparator Letrozole Other / unclassified 2.5 mg Oral

Indications